Stamellou, Eleni
Saritas, Turgay
Froissart, Marc
Kronenberg, Florian
Stenvinkel, Peter
Wheeler, David C.
Eckardt, Kai-Uwe
Floege, Jürgen
Fotheringham, James
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (445703531)
Bundesministerium für Bildung und Forschung (STOP-FSGS-01GM2202C)
Universitätsklinikum RWTH Aachen
Article History
Received: 9 December 2023
Accepted: 9 February 2024
First Online: 20 February 2024
Declarations
:
: Fresenius Medical Care (Europe) collected and processed data in accordance with all applicable local ethical and regulatory obligations concerning patient data for each of the 6 participating countries and licensed the anonymous data to Amgen. Informed patient consent was obtained from all patients by Fresenius Medical Care (Europe).
: Not applicable.
: Peter Stenvinkel: Advisory Boards and/or speaker honoraria for Astra Zeneca, Baxter Healthcare, Novo Nordisk, Vifor, Fresenius Medical Care, Invizius, Astellas, Glaxo Smith Beecham.Jürgen Floege: has received consultancy and speaker honoraria from Alnylam, AstraZeneca, Boehringer, Calliditas, CSL-ViforNovartis, Omeros, Travere.David C Wheeler: has received consultancy and speaker honoraria from Fresenius, Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Gilead, Janssen, Mundipharma, Merck Sharp and Dohme, Tricida, Vifor, Zydus.James Fotheringham: has received consultancy and speaker honoraria from Novartis, Fresenius and Boehringer Ingelheim. Grants from Vifor Pharma, Alnylam, Baxter Healthcare.Kai-Uwe Eckardt: has received consultancy and / or speaker honoraria from Astra Zeneca, Bayer, Boehringer Ingelheim, Enyo, Fresenius Medical Care, Glaxo Smith Kline, Otsuka, Sanofi, Travere.All other authors do not have conflict of interest.